| Bioactivity | 4,10-Dioxatri cyclo[5.2. 1.02.6]dec-8-ene-3,5-dione is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 4,10-Dioxatri cyclo[5.2. 1.02.6]dec-8-ene-3,5-dione |
| CAS | 5426-09-5 |
| Formula | C8H6O4 |
| Molar Mass | 166.13 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
4,10-Dioxatri cyclo[5.2. 1.02.6]dec-8-ene-3,5-dione
CAS: 5426-09-5 F: C8H6O4 W: 166.13
4,10-Dioxatri cyclodec-8-ene-3,5-dione is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor act
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.